| Metric | სს თბილისის თამბაქო | შპს ივერმედი | შპს გვირილა ინვესტი |
|---|---|---|---|
| Growth | |||
| Revenue | ₾45.0m₾42.7m | ₾45.9m₾47.1m | ₾42.7m₾42.3m |
| Revenue growth | 5.4% | -2.5% | 0.9% |
| Profitability | |||
| EBITDA | ₾14.7m₾11.1m | -₾1.1m₾3.1m | -₾1.2m-₾453k |
| EBITDA margin | 32.8%26.0% | -2.4%6.6% | -2.9%-1.1% |
| Net profit | ₾14.8m₾11.7m | -₾993k₾4.4m | -₾1.4m-₾709k |
| Net margin | 32.8%27.5% | -2.2%9.3% | -3.3%-1.7% |
| Balance sheet | |||
| Total assets | ₾58.2m₾52.8m | ₾38.9m₾42.4m | ₾3.7m₾3.0m |
| Total equity | ₾31.4m₾28.3m | ₾30.8m₾35.6m | -₾2.5m-₾1.1m |
| ROE | 47.0%41.3% | -3.2%12.3% | — |